Latest News in the pharma Industry

Top Stories

Roche Once Again Extends Illumina Bid

Roche Once Again Extends Illumina Bid

28 Mar 2012

The hostile approach, which is valued at approximately $5.7bn, will now give shareholders until April 20 to accept an offer of $44.50 per share.

Read more 
Daiichi Sankyo Announces New Global Corporate Slogan

Daiichi Sankyo Announces New Global Corporate Slogan

26 Mar 2012

The new slogan 'Passion for Innovation. Compassion for Patients.' will be rolled from April 1, 2012 via corporate advertisements, corporate websites and so on.

Read more 
Anaphore Acquires RuiYi in China

Anaphore Acquires RuiYi in China

26 Mar 2012

The acquisition of RuiYi allows Anaphore to access the substantial scientific expertise, capital and potential new collaboration opportunities in the Chinese pharmaceutical marketplace.

Read more 
Ablynx Extends Nanobody Pact with BI

Ablynx Extends Nanobody Pact with BI

26 Mar 2012

Ablynx has extended nanobody alliance with Boehringer Ingelheim.

Read more 
UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

22 Mar 2012

UCB will fund the collaboration with ?3.6 million over three years to develop medicines that will treat serious diseases in immunology and neurology.

Read more 
Abbott Announces Name for New Drug Company

Abbott Announces Name for New Drug Company

22 Mar 2012

The name for its new research-based pharmaceutical company is derived from a combination of Abbott and 'vie,' which references the Latin root 'vi' meaning life.

Read more 
Astellas Withdraws Application for Extension of Qutenza Indication

Astellas Withdraws Application for Extension of Qutenza Indication

21 Mar 2012

The company stated that it decided to withdraw the application based on the CHMP's view that the data provided do not allow the Committee to conclude on a positive benefit-risk balance.

Read more 
Eisai Expands Business in EMEA Region

Eisai Expands Business in EMEA Region

21 Mar 2012

The new expansion in the European, Middle Eastern and African markets is part of the company's plan to have a presence in the top 20 pharmaceutical market regions by 2015.

Read more 
Shire Licenses CNS Drug

Shire Licenses CNS Drug

21 Mar 2012

Heptares will receive an upfront option grant and exercise payments and is eligible to receive future development and commercial milestone payments of as much as $190 million, plus royalties on sales.

Read more 
SanBio Starts Enrollment in Clinical Trial of Stem Cell Therapy for Chronic Stroke

SanBio Starts Enrollment in Clinical Trial of Stem Cell Therapy for Chronic Stroke

21 Mar 2012

The stem cell therapy SB623 is derived from adult bone marrow and has shown safety and efficacy in rodent models of chronic stroke.

Read more 
Health Canada Facilitates Review Process to Ease Drug Shortage

Health Canada Facilitates Review Process to Ease Drug Shortage

21 Mar 2012

It usually takes around six months to complete an assessment and approve a drug for use in Canada. However, Health Canada is speeding up its drug review process to ease the drug shortage.

Read more 
Sigma-Aldrich Opens New Facility in China

Sigma-Aldrich Opens New Facility in China

19 Mar 2012

The new facility will provide localized packaging, analytical services and quality control for high-quality products to support the Company's research and industrial customers in the region.

Read more